A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray

Exclusion Criteria

• •1. Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
• •2. Pregnant or lactating women.
• •3. Upper respiratory infection within 14 days of study start.
• •4. Active asthma requiring treatment with inhaled or systemic steroids.
• •5. Use of any form of nasal spray during the previous month.